- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ER/PR/HER2 negative
Total 15899 results
-
Guangdong Provincial People's HospitalNot yet recruitingNeoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer
-
Abramson Cancer Center at Penn MedicineRecruitingBreast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | ER Positive Breast CancerUnited States
-
European Organisation for Research and Treatment...Breast International Group; Menarini GroupRecruitingStage IIB Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Stage III Breast CancerBelgium, Italy, Ireland, France, Germany
-
Columbia UniversityAvon FoundationCompletedInvasive Breast CancerUnited States
-
Sarah Sammons, MDDaiichi SankyoRecruitingBreast Cancer | Breast Cancer Female | Metastatic Triple-Negative Breast Carcinoma | HER2-negative Breast Cancer | HER2 Negative Breast Carcinoma | ER-negative Breast Cancer | ER Positive Breast CancerUnited States
-
Università degli Studi di FerraraUnknown
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruitingMetastatic Breast CancerUnited States
-
Shenzhen Yangli Pharmaceutical Technology Co., LtdRecruitingMetastatic Breast Cancer | ER+, HER2- Advanced Breast CancerChina
-
Western Regional Medical CenterTerminatedHER2-positive Breast Cancer | ER-positive Breast CancerUnited States
-
Institute of Cancer Research, United KingdomRecruitingBreast Cancer FemaleUnited Kingdom
-
Genentech, Inc.RecruitingEstrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Japan, Germany, Argentina, Turkey, Greece, Italy, Singapore, South Africa
-
Olema Pharmaceuticals, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2 Negative Breast Carcinoma | ER Positive Breast CancerUnited States, Korea, Republic of, Australia, Taiwan, Hong Kong, Malaysia, Thailand, Argentina, Belgium, Portugal, Italy, Czechia, Mexico, Poland
-
Massachusetts General HospitalExelixisActive, not recruitingBreast CancerUnited States
-
Merrimack PharmaceuticalsSanofiCompletedER Positive, Her2 Negative Breast Cancer Patients | Triple Negative Breast Cancer PatientsUnited States
-
BiogenCompletedMultiple SclerosisSweden, United Kingdom, Netherlands, Belgium, Canada, Italy
-
University of ArkansasCompleted
-
SanofiCompleted
-
University of Colorado, DenverUnited States Department of DefenseActive, not recruitingBreast CancerUnited States
-
Fondazione Sandro PitiglianiCompleted
-
University of Wisconsin, MadisonContext Therapeutics Inc.TerminatedMetastatic Cancer | ER-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
University of California, IrvineEli Lilly and CompanyTerminatedBreast Neoplasm | Hormone Receptor Positive Breast CarcinomaUnited States
-
University of AlbertaMcGill University; Université de Sherbrooke; University of TorontoCompletedChronic Obstructive Pulmonary Disease (COPD)Canada
-
Washington University School of MedicineBiovicaNot yet recruitingMetastatic Breast Cancer | Unresectable Breast CancerUnited States
-
S Form PharmaRecruitingLongitudinal Observational Study With 6 Months Follow-upTunisia
-
José Casaña GranellUniversity of Alcalá. Physiotherapy in Women's Health (FPSM) Research Group.CompletedUrinary Incontinence | Pelvic Floor Disorders | Pelvic Floor Muscle Weakness | Urinary Incontinence,StressSpain
-
Soroka University Medical CenterUnknownAsthma ExacerbationIsrael
-
AstraZenecaCompletedPostmenopausal Women With ER+ HER2- Primary Breast CancerGermany, United Kingdom
-
Fondazione Salvatore MaugeriCompletedChronic Obstructive Pulmonary DiseaseItaly
-
Providence Health & ServicesMerck Sharp & Dohme LLCActive, not recruitingTriple Negative Breast CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...Beijing Huanxing Cancer Hospital; Cancer Hospital, Chinese Academy of Medical...RecruitingEarly-stage Breast CancerChina
-
Novartis PharmaceuticalsCompleted
-
Gary SchwartzWithdrawn
-
University of Colorado, DenverUnited States Department of DefenseCompleted
-
University of GlasgowNHS Research and DevelopmentCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
University of Missouri-ColumbiaInstitute of Mental Health, Singapore; University of Missouri, St. LouisCompleted
-
Aveiro UniversityFundação para a Ciência e a TecnologiaCompletedChronic Obstructive Pulmonary Disease (COPD)Portugal
-
Vedic Lifesciences Pvt. Ltd.Completed
-
British Columbia Cancer AgencyGenomic Health®, Inc.Not yet recruiting
-
Laboratoires URGOUnknownDiabetic Foot UlcerCzechia, France, Italy, Poland, Spain, United Kingdom
-
University Hospital, AkershusVestre Viken Hospital Trust; NovartisRecruitingBreast Cancer | Locally Advanced Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Luminal A Breast Cancer | Luminal B Breast CancerNorway
-
ETOP IBCSG Partners FoundationCompleted
-
Dartmouth-Hitchcock Medical CenterTerminatedBreast CancerUnited States
-
Fu Jen Catholic UniversityRecruiting
-
Novartis PharmaceuticalsCompletedBreast CancerIndia, Malaysia, Saudi Arabia, Taiwan, Russian Federation, Lebanon, South Africa, Thailand, Jordan, Turkey, Egypt, Vietnam, Singapore
-
AstraZenecaCompleted
-
Fuzhou General HospitalTerasaki FoundationUnknownRenal Transplantation | UremiaChina
-
Nantes University HospitalCompletedPrimary Raynaud's Phenomenon (PR) | Genetic Mutations Causing PR | Study of Patients and Their Relatives (With or Without Primary PR)France
-
AstraZenecaRecruitingER+ HER2- Advanced Breast Cancer | High-grade Serous Ovarian Cancer (HGSOC)United States, United Kingdom, Korea, Republic of, Australia, Spain
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsTerminated